Skip to main content
Atencion Primaria logoLink to Atencion Primaria
letter
. 2013 Apr 3;32(6):393–394. [Article in Spanish] doi: 10.1016/S0212-6567(03)79306-8

¿Interacciones o asociaciones potencialmente peligrosas?

FJ Morales Olivas 1, L Estañ Yago 1
PMCID: PMC7684428  PMID: 14572409

The content is available as a PDF (68.4 KB).

Bibliografía

  • 1.Álvarez Gutiérrez J.M., López-Torres Hidalgo J.D., Galdón Blesa P., García Ruiz E.M., Naharro de Mora F. Interacciones farmacológicas de las estatinas. Aten Primaria. 2003;31:222–226. doi: 10.1016/S0212-6567(03)79163-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Note for guidance on the investigation of drug interactions. Committee for proprietary medicinal products (CPMP) The European Agency for the evaluation of Medicinal Products; London: 1997. (CPMP/EWP/560/95) [Google Scholar]
  • 3.Grau E., Perella M., Pastor E. Simvastatin-oral anticoagulant interaction. Lancet. 1996;347:405–406. doi: 10.1016/s0140-6736(96)90589-9. [DOI] [PubMed] [Google Scholar]
  • 4.Paoletti R., Corsini A., Bellosta S. Pharmacological interactions of statins. Atheroscler. 2002;3(suppl):35–40. doi: 10.1016/s1567-5688(02)00002-8. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES